Théa and Kiora Pharmaceuticals sign a new partnership
Kiora Pharmaceuticals and Théa Open Innovation Enter Strategic Agreement
©Zhiguo He
Kiora Pharmaceuticals and Théa Open Innovation Enter Strategic Agreement
Deal with Laboratoires Théa representing a total value of up to $280 million including clinical, regulatory and commercial conditional milestones, commercial royalties, and development responsibility for Phase
Clermont-Ferrand, France, Wednesday 1 October 2025 – Sepul Bio, an innovative business unit of Théa, dedicated to the advancement of RNA therapies for inherited retinal diseases, has
Théa and Link Biologics sign a new partnership
Théa and ProQR Therapeutics sign a new partnership
Théa and Olix Pharmaceuticals sign a new partnership
Théa and Gallimedix, Inc sign a new partnership
Théa Open Innovation and CURACLE sign a new partnership
Théa and Coave Therapeutics announce their partnership
Théa and Coave Therapeutics announce their partnership